Adolescent HBV immunisation: 2 shots enough

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1291, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection

By Gabutti G.

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

Age, genotype predict efficacy of interferon-α-2b against HBV

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Cost-Benefit Model Comparing Two Alternative Immunisation Programmes Against Serogroup C Meningococcal Disease: For Quebec Residents Aged 2 Months to 20 Years

By Rancourt C.

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 429-442

Adis International

Access to resources Recommend Favorite

Danish immunisation programme "safe"

Reactions Weekly, Vol. 1, Iss. 1387, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Technologies to Improve Immunisation Safety

By Clements C.J. Aguado M.T. Jódar L.

Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. : 1019-1026

Adis International

Access to resources Recommend Favorite